Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Aiyin Chen, Stanton Glantz, Elisa Tong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVE: To describe the development and health claims of Asian herbal-tobacco cigarettes. METHODS: Analysis of international news sources, company websites, and the transnational tobacco companies' (TTC) documents. PubMed searches of herbs and brands. RESULTS: Twenty-three brands were identified, mainly from China. Many products claimed to relieve respiratory symptoms and reduce toxins, with four herb-only products advertised for smoking cessation. No literature was found to verify the health claims, except one Korean trial of an herb-only product. Asian herbal-tobacco cigarettes were initially produced by China by the 1970s and introduced to Japan in the 1980s. Despite initial news about research demonstrating a safer cigarette, the TTC analyses of these cigarettes suggest that these early products were not palatable and had potentially toxic cardiovascular effects. By the late 1990s, China began producing more herbal-tobacco cigarettes in a renewed effort to reduce harmful constituents in cigarettes. After 2000, tobacco companies from Korea, Taiwan, and Thailand began producing similar products. Tobacco control groups in Japan, Taiwan, and Thailand voiced concern over the health claims of herbal-tobacco products. In 2005, China designated two herbal-tobacco brands as key for development. CONCLUSION: Asian herbal-tobacco cigarettes claim to reduce harm, but no published literature is available to verify these claims or investigate unidentified toxicities. The increase in Asian herbal-tobacco cigarette production by 2000 coincides with the Asian tobacco companies' regular scientific meetings with TTCs and their interest in harm reduction. Asia faces additional challenges in tobacco control with these culturally concordant products that may discourage smokers from quitting.

Original languageEnglish (US)
JournalTobacco Control
Volume16
Issue number2
StatePublished - Apr 2007

Fingerprint

Tobacco Products
nicotine
Tobacco
Medicine
medicine
China
Thailand
Taiwan
Japan
Health
news
health
Tobacco Use Cessation Products
Harm Reduction
Poisons
Korea
PubMed
website
smoking
Control Groups

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health Policy
  • Epidemiology

Cite this

Asian herbal-tobacco cigarettes : "not medicine but less harmful"? / Chen, Aiyin; Glantz, Stanton; Tong, Elisa.

In: Tobacco Control, Vol. 16, No. 2, 04.2007.

Research output: Contribution to journalArticle

@article{e611a8ff93dd4af989f221e05647b8ac,
title = "Asian herbal-tobacco cigarettes: {"}not medicine but less harmful{"}?",
abstract = "OBJECTIVE: To describe the development and health claims of Asian herbal-tobacco cigarettes. METHODS: Analysis of international news sources, company websites, and the transnational tobacco companies' (TTC) documents. PubMed searches of herbs and brands. RESULTS: Twenty-three brands were identified, mainly from China. Many products claimed to relieve respiratory symptoms and reduce toxins, with four herb-only products advertised for smoking cessation. No literature was found to verify the health claims, except one Korean trial of an herb-only product. Asian herbal-tobacco cigarettes were initially produced by China by the 1970s and introduced to Japan in the 1980s. Despite initial news about research demonstrating a safer cigarette, the TTC analyses of these cigarettes suggest that these early products were not palatable and had potentially toxic cardiovascular effects. By the late 1990s, China began producing more herbal-tobacco cigarettes in a renewed effort to reduce harmful constituents in cigarettes. After 2000, tobacco companies from Korea, Taiwan, and Thailand began producing similar products. Tobacco control groups in Japan, Taiwan, and Thailand voiced concern over the health claims of herbal-tobacco products. In 2005, China designated two herbal-tobacco brands as key for development. CONCLUSION: Asian herbal-tobacco cigarettes claim to reduce harm, but no published literature is available to verify these claims or investigate unidentified toxicities. The increase in Asian herbal-tobacco cigarette production by 2000 coincides with the Asian tobacco companies' regular scientific meetings with TTCs and their interest in harm reduction. Asia faces additional challenges in tobacco control with these culturally concordant products that may discourage smokers from quitting.",
author = "Aiyin Chen and Stanton Glantz and Elisa Tong",
year = "2007",
month = "4",
language = "English (US)",
volume = "16",
journal = "Tobacco Control",
issn = "0964-4563",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Asian herbal-tobacco cigarettes

T2 - "not medicine but less harmful"?

AU - Chen, Aiyin

AU - Glantz, Stanton

AU - Tong, Elisa

PY - 2007/4

Y1 - 2007/4

N2 - OBJECTIVE: To describe the development and health claims of Asian herbal-tobacco cigarettes. METHODS: Analysis of international news sources, company websites, and the transnational tobacco companies' (TTC) documents. PubMed searches of herbs and brands. RESULTS: Twenty-three brands were identified, mainly from China. Many products claimed to relieve respiratory symptoms and reduce toxins, with four herb-only products advertised for smoking cessation. No literature was found to verify the health claims, except one Korean trial of an herb-only product. Asian herbal-tobacco cigarettes were initially produced by China by the 1970s and introduced to Japan in the 1980s. Despite initial news about research demonstrating a safer cigarette, the TTC analyses of these cigarettes suggest that these early products were not palatable and had potentially toxic cardiovascular effects. By the late 1990s, China began producing more herbal-tobacco cigarettes in a renewed effort to reduce harmful constituents in cigarettes. After 2000, tobacco companies from Korea, Taiwan, and Thailand began producing similar products. Tobacco control groups in Japan, Taiwan, and Thailand voiced concern over the health claims of herbal-tobacco products. In 2005, China designated two herbal-tobacco brands as key for development. CONCLUSION: Asian herbal-tobacco cigarettes claim to reduce harm, but no published literature is available to verify these claims or investigate unidentified toxicities. The increase in Asian herbal-tobacco cigarette production by 2000 coincides with the Asian tobacco companies' regular scientific meetings with TTCs and their interest in harm reduction. Asia faces additional challenges in tobacco control with these culturally concordant products that may discourage smokers from quitting.

AB - OBJECTIVE: To describe the development and health claims of Asian herbal-tobacco cigarettes. METHODS: Analysis of international news sources, company websites, and the transnational tobacco companies' (TTC) documents. PubMed searches of herbs and brands. RESULTS: Twenty-three brands were identified, mainly from China. Many products claimed to relieve respiratory symptoms and reduce toxins, with four herb-only products advertised for smoking cessation. No literature was found to verify the health claims, except one Korean trial of an herb-only product. Asian herbal-tobacco cigarettes were initially produced by China by the 1970s and introduced to Japan in the 1980s. Despite initial news about research demonstrating a safer cigarette, the TTC analyses of these cigarettes suggest that these early products were not palatable and had potentially toxic cardiovascular effects. By the late 1990s, China began producing more herbal-tobacco cigarettes in a renewed effort to reduce harmful constituents in cigarettes. After 2000, tobacco companies from Korea, Taiwan, and Thailand began producing similar products. Tobacco control groups in Japan, Taiwan, and Thailand voiced concern over the health claims of herbal-tobacco products. In 2005, China designated two herbal-tobacco brands as key for development. CONCLUSION: Asian herbal-tobacco cigarettes claim to reduce harm, but no published literature is available to verify these claims or investigate unidentified toxicities. The increase in Asian herbal-tobacco cigarette production by 2000 coincides with the Asian tobacco companies' regular scientific meetings with TTCs and their interest in harm reduction. Asia faces additional challenges in tobacco control with these culturally concordant products that may discourage smokers from quitting.

UR - http://www.scopus.com/inward/record.url?scp=35748976603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748976603&partnerID=8YFLogxK

M3 - Article

C2 - 17400933

AN - SCOPUS:35748976603

VL - 16

JO - Tobacco Control

JF - Tobacco Control

SN - 0964-4563

IS - 2

ER -